Canopy Biosciences RareSeq

Canopy Biosciences has launched its RareSeq error corrected sequencing service. The technology removes errors generated during next generation sequencing to separate rare mutations from background noise. Canopy is launching the service with a panel of genetic variants linked to myeloid diseases, aiming to offer users a tool to study to study disease development, progression, and recurrence. The firm said that the panel targets 54 genes that are often mutated in myeloid malignancies.